Literature DB >> 12933849

Cloning and characterization of a gene encoding an immunoglobulin-binding receptor on the cell surface of some members of the family Trypanosomatidae.

Antonio Campos-Neto1, Isabelle Suffia, Karen A Cavassani, Shyian Jen, Kay Greeson, Pamela Ovendale, João S Silva, Steven G Reed, Yasir A W Skeiky.   

Abstract

Several members of the Trypanosomatidae family, when freshly isolated from their mammalian hosts, have immunoglobulins adsorbed to their cell surfaces. However, a significant portion of these antibody molecules is not parasite specific, i.e., the immunoglobulins are bound to the parasite's cell surface molecules via noncognitive interactions. It has been proposed that this noncognitive adsorption of immunoglobulins to the parasite is mediated by an Fc-like receptor present in several members of the Trypanosomatidae family. However, the molecular identification of this receptor has never been defined. Here, we describe the cloning of a gene encoding a protein that might represent this molecule. The gene, named Lmsp1, was cloned by screening a Leishmania major cDNA expression library using a rabbit antiserum. Lmsp1 is present in both Leishmania and Trypanosoma and is expressed in all developmental stages of these parasites. The predicted protein has a molecular mass of 16.6 kDa and contains an RGD sequence starting at residue 104 and three cysteine residues at positions 55, 74, and 116. The purified recombinant protein strongly binds to normal immunoglobulins of various animal species (humans, rabbits, sheep, goats, guinea pigs, donkeys, rats, and mice) and the binding to human immunoglobulins appears to be immunoglobulin G (IgG) and IgM isotype specific. Moreover, Lmsp1 binds to both purified Fc and Fab fragments of IgG from both humans and rabbits. The mapping of the Lmsp1 epitopes that bind human IgG revealed that different sequences of the molecule bind to Fc or Fab. In addition, fluorescence-activated cell sorter analyses with a specific rabbit anti-Lmsp1 antiserum showed that Lmsp1 is associated with the parasite's cell surface. Finally, inhibition experiments point to an active role of this molecule in the immunoglobulin-mediated attachment and penetration of Trypanosoma cruzi in its macrophage host cells, thus suggesting that Lmsp1 is a putative Trypanosomatidae immunoglobulin receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933849      PMCID: PMC187365          DOI: 10.1128/IAI.71.9.5065-5076.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  New perspectives in cell adhesion: RGD and integrins.

Authors:  E Ruoslahti; M D Pierschbacher
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

2.  Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes.

Authors:  M E Wilson; R D Pearson
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

3.  The major surface protein of Leishmania promastigotes is a fibronectin-like molecule.

Authors:  F S Rizvi; M A Ouaissi; B Marty; F Santoro; A Capron
Journal:  Eur J Immunol       Date:  1988-03       Impact factor: 5.532

4.  Streptococcal protein G has affinity for both Fab- and Fc-fragments of human IgG.

Authors:  M Erntell; E B Myhre; U Sjöbring; L Björck
Journal:  Mol Immunol       Date:  1988-02       Impact factor: 4.407

5.  Protein A reactivity of lymphocytes from some patients with chronic lymphocytic leukaemia mediated by an interaction with the F(ab')2 region of surface immunoglobulin.

Authors:  S Romagnani; M G Guidizi; R Biagiotti; F Almerigogna; G F Del Prete; E Maggi; M Ricci
Journal:  Scand J Immunol       Date:  1982-03       Impact factor: 3.487

6.  Purification and some properties of streptococcal protein G, a novel IgG-binding reagent.

Authors:  L Björck; G Kronvall
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

7.  Host and parasite factors affecting the invasion of mononuclear phagocytes by Trypanosoma cruzi.

Authors:  N Nogueira
Journal:  Ciba Found Symp       Date:  1983

8.  Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism.

Authors:  M E Wilson; R D Pearson
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

9.  Complement receptor type 3 (CR3) binds to an Arg-Gly-Asp-containing region of the major surface glycoprotein, gp63, of Leishmania promastigotes.

Authors:  D G Russell; S D Wright
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

10.  Receptor for immunoglobulin Fc on pathogenic but not on nonpathogenic protozoa of the Trypanosomatidae.

Authors:  I K De Miranda-Santos; A Campos-Neto
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

View more
  4 in total

1.  Upregulated expression of B-cell antigen family tandem repeat proteins by Leishmania amastigotes.

Authors:  Yasuyuki Goto; Darrick Carter; Jeffrey Guderian; Noboru Inoue; Shin-Ichiro Kawazu; Steven G Reed
Journal:  Infect Immun       Date:  2010-02-16       Impact factor: 3.441

2.  Urine-based antigen detection assay for diagnosis of visceral leishmaniasis using monoclonal antibodies specific for six protein biomarkers of Leishmania infantum / Leishmania donovani.

Authors:  Claudia Abeijon; Fabiana Alves; Séverine Monnerat; Jane Mbui; Agostinho G Viana; Raquel M Almeida; Lilian L Bueno; Ricardo T Fujiwara; Antonio Campos-Neto
Journal:  PLoS Negl Trop Dis       Date:  2020-04-23

3.  Comment on "Regulation of immunity during visceral Leishmania infection" and further discussions about the role of antibodies in infections with Leishmania.

Authors:  Luiz Gustavo Gardinassi; Isabel Kinney Ferreira de Miranda Santos
Journal:  Parasit Vectors       Date:  2016-07-07       Impact factor: 3.876

4.  CD271+ Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum.

Authors:  Carolina S Lopes; Nada Daifalla; Bikul Das; Valdo Dias da Silva; Antonio Campos-Neto
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.